Spectranetics Names New CFO

Colorado Springs, Colo.-based Spectranetics Corp. has named Stacy McMahan as its new chief financial officer. She replaces Guy Childs, who is moving to a new role within the company as vice president overseeing treasury, investor relations and financial planning. In her new role, McMahan will report directly to President and CEO Scott Drake.

McMahan has more than 25 years of finance leadership experience, including Chief Financial Officer and Vice President of Finance with responsibility for global, treasury, tax, internal audit, and decision support groups of high-profile public companies. She currently serves as senior vice president, chief financial officer and treasurer of MSA Safety Inc. Prior to joining MSA, McMahan was employed by Thermo Fisher Scientific Inc., where she served as vice president of finance, Customer Channels Group. Prior to that, she spent six years with Johnson & Johnson as vice president of finance, and 16 years with Eli Lilly, where she served in several significant roles across many countries.

“Stacy is a proven executive with world-class finance, operations, and business development experience,” said Drake. “In addition to her financial background and prior experience with large, publicly held companies, Stacy brings a deep understanding of the medical device industry to this critical role. Her skills and leadership will help us capitalize on the transformational opportunities ahead. I am confident that, with the benefit of Guy Childs’ continued contribution and leadership, there will be a seamless transition as we execute our strategic plan.”

Ms. McMahan stated, “I am thrilled to join Spectranetics. The strategic growth opportunities for the company are compelling, and the mission of saving limbs and lives has never been more important. I look forward to being an integral part of the team at Spectranetics and helping to drive further success for the company.”

McMahan earned a Bachelor of Science degree in finance from Oklahoma State University and an MBA from Harvard Business School.

Spectranetics makes minimally invasive technology for procedures within the cardiovascular system.